Cervical Cancer Diagnostics and Therapeutics Market by diagnostics test, by methods, by therapies (surgery, radiation therapy, chemotherapy and others), by end-users (hospitals, laboratories, independent physicians, clinics, and others), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
The Global Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 3540.00 Million in 2016 and is projected to reach USD 4411.48 Million by 2021, at a CAGR of 4.5% during the forecast period from 2016 to 2021. Cervical cancer is generally characterized by the abnormal growth of cancerous cells in the tissues of the cervix, and it may manifest itself as a squamous-cell carcinoma or adenocarcinoma.
More than 15% of cases of cervical cancer are found in women over 65. The first step in finding cervical cancer is often an abnormal Pap test result.
The factors that are driving the global market for Cervical Cancer Diagnostics and Therapeutics are rising prevalence of cervical cancer, increasing public awareness about cancer and also developing technologies in treating cancer. However, the market growth is constrained due to uncertain regulatory guidelines and high costs of screening test.
Browse market data tables and in-depth TOC of the Global Cervical Cancer Diagnostics and Therapeutics Industry to 2021 at www.marketdataforecast.com/market-…utics-market-829/
Global market for Cervical Cancer Diagnostics and Therapeutics is segmented based on diagnostics test, methods, end-users and therapies. By Diagnostics test, the market is further sub-segmented into Pap smear test, HPV testing, colposcopy, cervical cancer biopsy.
By methods, the market is further sub-segmented into molecular method, cytopathological method, and physical method. By therapies, the market is further sub-segmented into surgery, radiation therapy, chemotherapy and others.
By end-users, the market is further sub-segmented into hospitals, laboratories, independent physicians, clinics, and others. Pap smear test segment dominated the market by Diagnostic test, holding a 45% share in the global market for cervical cancer diagnostic tests.
The high growth rate of this segment can be attributed to the high efficiency of the test, low cost of the test in comparison with other tests available in the market, and rising awareness regarding cancer diagnosis.
Geographically, Global market for Cervical Cancer Diagnostics and Therapeutics is segmented into North America, Asia Pacific, Latin America, Europe, and Africa & Middle-East. North America holds the largest share of the global market, followed by Europe.
A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing market in the North American region. Asia Pacific market is growing at very high rate, due to rising consumer market, favorable government support for enhanced healthcare infrastructure, and rising awareness for healthcare among the population in developing nations of the region.
Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx, are the major players of Global Cervical Cancer Diagnostics and Therapeutics market.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!